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Antibacterial activity and effect on 
gingival cells of microwave-pulsed 
non-thermal atmospheric pressure 
plasma in artificial saliva
Sang-Hee Seo1,2, Ihn Han  3, Han Seol Lee3, Jin Joo Choi3, Eun Ha Choi3, Kyoung-Nam Kim1,2, 
Gyungsoon Park3 & Kwang-Mahn Kim1,2
Although various oral pathogens are inactivated by non-thermal atmospheric pressure plasma 
(NTAPP), the in vivo effects of NTAPP are poorly understood. The first aim of this study was to examine 
the antibacterial activity of microwave-pulsed NTAPP against Staphylococcus aureus in artificial saliva 
to mimic oral environmental conditions. The second aim was to determine the influence of microwave-
pulsed NTAPP on human gingival fibroblasts (HGFs). The microwave-pulsed NTAPP reduced bacterial 
viability (as measured by colony forming units [CFU]) to a greater extent in artificial saliva than in 
saline. Extending the post-treatment incubation time increased bacterial inactivation in artificial 
saliva compared to saline. HGFs viability was unaffected by microwave-pulsed NTAPP for bacterial 
inactivation. Rather, HGFs proliferation increased after a 5-min microwave-pulsed NTAPP. Less 
tumor necrosis factor alpha was released by microwave-pulsed NTAPP-treated HGFs stimulated with 
lipopolysaccharide (LPS) than by untreated, LPS-stimulated HGFs; thus, plasma appeared to suppress 
the inflammatory response. Our study suggests that microwave-pulsed NTAPP may have stronger 
in vivo antibacterial activity than in vitro activity, and that microwave-pulsed NTAPP may have the 
additional advantage of suppressing gingival inflammatory responses.
Periodontitis, an inflammatory disease affecting tooth-supporting tissues, is caused by chronic bacterial infec-
tion that destroys the gums and jaw bones. Lipopolysaccharide (LPS) and peptidoglycan from bacterial cell sur-
faces induce host tooth immune responses including production of pro-inflammatory cytokines and subsequent 
inflammatory responses1. After immune response initiation, host cells produce reactive oxygen species (ROS), 
cytokines, procoagulants, and other small molecules that amplify and sustain the inflammatory response, while 
causing progressive tissue destruction2. A variety of cytokines, including interleukin (IL)-1α, IL-1β, IL-6, IL-8, 
tumor necrosis factor alpha (TNF-α), CD14, and Toll-like receptors, have been detected in inflammatory gingival 
tissues with periodontitis1. TNF-α is a well-established pro-inflammatory cytokine involved in the regulation of 
infection, inflammation, and autoimmune phenomena1. Many studies have shown that some cytokines, includ-
ing TNF-α, play a primary role in microbial pathogenesis3, 4. In severe cases of periodontitis, locally produced, 
pro-inflammatory cytokines can enter systemic circulation and induce an acute liver response5.
Safe, effective, and economic methods have been developed to cure and prevent periodontal disease by con-
trolling bacterial infection6. Several antibiotics and therapies (eg, scaling, root planning, medication, surgical 
treatments [flap surgery], flossing, brushing, rinsing, and laser treatments) have been used to eliminate bacteria 
that may cause periodontal disease6–10. A recent study suggested that, because ROS levels are an important factor 
in periodontal disease pathogenesis, ROS control may play a key role in periodontal disease prevention11. Indeed, 
ROS-reducing antioxidant therapy can control bacterial infection and produce anti-inflammatory effects on per-
iodontal tissues11, 12. Although there are a variety of periodontitis treatments available, the search for reliable, 
multidisciplinary cures is ongoing.
1Department and Research Institute of Dental Biomaterials and Bioengineering, Yonsei University College of 
Dentistry, Seoul, 03722, Korea. 2BK21 PLUS Project, Yonsei University College of Dentistry, Seoul, 03722, Korea. 
3Plasma Bioscience Research Center, Kwangwoon University, Seoul, 01897, Korea. Correspondence and requests for 
materials should be addressed to G.P. (email: gyungp@kw.ac.kr) or K.-M.K. (email: kmkim@yuhs.ac)
Received: 13 January 2017
Accepted: 17 July 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 8395  | DOI:10.1038/s41598-017-08725-0
Non-thermal atmospheric pressure plasma (NTAPP) is being explored as a potential tool to control bacterial 
infections associated with periodontitis13. NTAPP antimicrobial activity against oral bacteria and biofilms has 
been demonstrated14. In particular, microwave-generated plasma has been used to inactivate bacteria because of 
its low cost, simplicity, and ease of preparation15–17. Needed microwave devices can be constructed at relatively 
low cost because electrodes are not required to generate microwave plasma18, 19. Short-lived reactive chemical 
species created by microwave plasma will destroy microorganisms by reacting with cell wall hydrocarbon bonds, 
then with reaction by-products such as CO, CO2, and OH radicals. Thus, the outer cell wall may be removed 
initially, and continued reactions will destroy the secondary cell wall20. Through this mechanism, it is possible 
that microwave plasma could have prolonged effects on bacterial disinfection or sterilization21–24. Despite these 
advantages, several weaknesses require technical improvement. Ozone is produced during plasma generation 
and plays an important role in microbe inactivation25; however, ozone can be inhaled during treatment. Another 
problem is that efficiency of plasma sterilization can vary by microbial species and environment26. Optimization 
of plasma sources is needed to make use of plasma as a general sterilization tool.
Although research to clarify the properties and mechanisms of antibacterial plasma activity is increasing27, 
substantially more evidence is needed to prove the efficacy of plasma technology in treating in vivo oral infection. 
The interaction of plasma with the oral microenvironment is poorly understood, and antibacterial activity should 
be tested under conditions mimicking that environment using saliva before NTAPP therapy can be used clini-
cally. Moreover, the influence of NTAPP on surrounding tissues should be considered.
In this study, we assessed the ability of microwave-pulsed NTAPP to inactivate Staphylococcus aureus in arti-
ficial saliva. Secondly, we investigated the influence of microwave-pulsed NTAPP on inflammatory responses of 
surrounding tissue cells. Although artificial saliva does not provide a true representation of saliva, it has been used 
to mimic the oral environment28. S. aureus, a gram-positive bacteria well-known for its biofilm formation29, is 
the most commonly found staphylococcal species in the oral cavity. It is thought to be responsible for infectious 
endocarditis through oral-nasal trafficking30. Therefore, understanding the effects of plasma on S. aureus may 
provide information that is applicable to other oral bacteria.
Results
Physical and chemical properties of microwave plasma. The optical emission spectrum of micro-
wave-pulsed NTAPP (Fig. 1a) with Argon (Ar) feeding gas is shown in Fig. 1b. Ar emission lines were detected 
in the 650 to 950 nm wavelength range, whereas nitrogen second positive system and OH emission bands were 
observed at wavelengths in the 330 to 400 nm and 306 to 309 nm ranges, respectively (Fig. 1b). To optimize 
conditions for microwave-pulsed NTAPP, the temperature of a 1 ml water sample was monitored over different 
treatment times, sample-plasma plume distances, and gas flow rates. The temperature of the sample was stable at 
approximately 23 °C for up to 10 min when treated at 10 mm from the tip of the plasma plume with a 2 L/min gas 
flow (Fig. 1c). This treatment condition was used in all subsequent experiments to avoid heating effects.
Inactivation of Staphylococcus aureus in artificial saliva by microwave plasma. Figure 2 shows 
the antibacterial activity of microwave-pulsed NTAPP in saline and artificial saliva. In both solutions, the num-
bers of viable bacteria were significantly decreased after microwave-pulsed NTAPP in a treatment time-dependent 
manner, with the decrease occurring more rapidly in artificial saliva compared to saline (Fig. 2a). When bacteria 
were incubated for 30 min after treatment, reductions in colony forming units (CFU) were greater in artificial 
saliva compared to saline (Fig. 2a). CFU were reduced following exposure to plasma in artificial saliva for 5 min 
and 7 min (P < 0.05 for both). Notably, we observed an almost 4-log reduction in CFU following a 7-min treat-
ment and 30 min incubation (Fig. 2a). The relative viability of plasma-treated bacterial cells (vs gas only treatment 
control) was much smaller in artificial saliva than in saline for the same treatment time; the difference became 
more distinct after a 30-min incubation (Fig. 2b). These results indicate that our plasma is more toxic to bacteria 
in artificial saliva than in saline and that a longer incubation enhances this bactericidal effect.
Bacteria subjected to plasma treatment in artificial saliva had dramatically altered morphology (Fig. 3). Most 
bacterial cells treated with plasma for 5 min in artificial saliva were crushed and torn, whereas control cells treated 
only with gas retained their spherical shapes (Fig. 3).
Analysis of solutions after plasma treatment. Plasma treatment for 5 min altered the pH of saline more 
than it altered the pH of artificial saliva (Fig. 4a). After a 5-min plasma treatment, the saline pH (4.91 ± 0.04) 
was markedly lower than the untreated saline pH (6.26 ± 0.00). In contrast, the pH of artificial saliva after 5-min 
plasma treatment (5.59 ± 0.03) was only slightly lower than that of untreated saliva (5.66 ± 0.03; Fig. 4a). This 
finding may be explained by the presence of phosphate and urea, which can act as buffers in artificial saliva. 
Conversely, the plasma treatment increased OH radical levels to the greatest extent in artificial saliva, to a lesser 
extent in saline, but not in the gas only control (Fig. 4b). The increases for artificial saliva and saline were far 
greater after 5-min treatment than after 1-min treatment. NO levels were increased following the 5-min plasma 
treatment in saline, but only negligibly in artificial saliva (Fig. 4c).
Although OH radical levels were higher in plasma-treated artificial saliva than in saline, they were not suffi-
cient to explain the increased antibacterial activity of plasma in artificial saliva. To investigate longer-term chemi-
cal changes that may explain the observed increased bactericidal activity in artificial saliva, we quantified bacteria 
viability in artificial saliva samples by individually omitting chemicals. When samples were treated with plasma 
for 1 min and 3 min, bacterial viability was slightly reduced in artificial saliva that lacked individual chemicals, 
even after 30 min of incubation (Fig. 5). There were no differences in reduction patterns by specific chemical 
omitted; however, the viability reduction was less pronounced in artificial saliva lacking urea (Fig. 5). Five-minute 
treatment reduced bacterial viability markedly when any constituent chemical was omitted (Fig. 5). These results 
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suggest that synergistic interactions among chemicals may play a crucial role in the observed antibacterial prop-
erties of plasma.
We found that continuous plasma exposure led to more bacterial inactivation (with or without a 30-min incu-
bation) than administration of plasma-treated solutions. Bacterial viability was reduced more by direct plasma 
treatment in saline and artificial saliva than by treatment in saline or artificial saliva pre-exposed to plasma; this 
difference was amplified after a 30-min incubation (Fig. 6). Finally, bacterial viability was decreased more in arti-
ficial saliva than in saline, with or without incubation, following direct plasma treatment and following treatment 
with plasma pre-exposed solutions (Fig. 6).
Viability and inflammatory responses of gingival cells after plasma treatment. As shown 
in Fig. 7a, HGFs viability was not affected by 1-min or 3-min plasma treatment at the same dose described 
Figure 1. (a) Schematic view of microwave-pulsed non-thermal atmospheric pressure plasma (NTAPP) 
impedance system. (b) Optical emission spectra of microwave-pulsed NTAPP with Argon (Ar) gas; Ar emission 
lines at 650 to 950 nm; OH emission band at 306 to 309 nm; and nitrogen second positive system at 330 to 
400 nm. (c) Temperature of deionized water treated with microwave-pulsed NTAPP for different lengths of 
time. The distance between the upper surface of the solution and the bottom of the plasma plume was 10 mm.
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previously. Interestingly, increased cell proliferation was observed after 5 min in the plasma treatment sample 
compared to the gas only control treatment or no treatment.
HGFs viability did not change with LPS doses less than 1.0 µg/ml, but did decrease slightly following admin-
istration of 1.0 µg/ml or 2.0 µg/ml LPS (Fig. 7b). Thus, for subsequent cytokine experiments, a 1.0 µg/ml LPS con-
centration was used to induce inflammatory responses in HGFs with minimal reduction in cell viability. Levels of 
TNF-α released from plasma-treated cells were much lower following LPS stimulation than levels observed for 
untreated plasma cells, but similar to those observed in control cells that were not LPS-stimulated (Fig. 7c, bottom 
graph). This finding suggests that plasma treatment may be able to suppress, at least partially, the gingival inflam-
matory response. The TNF-α–releasing effect of LPS on HGFs was blocked by plasma treatment at 1 min, 3 min, 
5 min, and 10 min. Moreover, the cell viability-reducing effect of LPS stimulation was countered effectively using 
plasma treatment for 1 min, 3 min (viability greater than no LPS), or 5 min (Fig. 7c, upper graph). LPS-exposed 
HGFs treated with plasma for 10 min, however, had reduced cell viability relative to control cells not exposed to 
LPS (Fig. 7c upper graph).
Discussion
Our study results have several important implications for the management of periodontal disease using plasma 
in vivo. First, microwave plasma may be more effective in a real oral environment including saliva than under 
experimental conditions. Although artificial saliva does not provide a true replication of the oral environment, it 
did inactivate microbes at a rate that was orders of magnitude greater than the rate in saline. Until now, the effect 
Figure 2. (a) Bacterial viability measured as colony forming units (CFU) on a log scale after plasma treatment 
in saline or artificial saliva, with or without 30-min incubation. (b) Relative viability of plasma-treated bacteria 
compared to gas only control treatment. Relative viability (%) = (CFU after plasma treatment/CFU after gas 
treatment) ×100. All values are means ± standard deviations of triplicate measurements, and all experiments 
were repeated three times. *P < 0.05.
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of plasma has not been studied extensively with real saliva, but it has been used occasionally to test for corrosivity 
of plasma to treated titanium surfaces28. Because real saliva is a complex system, our results using artificial saliva 
may be too preliminary to apply to the oral environment. However, these results do provide some understanding 
of the antibacterial activity of plasma in vivo. We will further investigate antibacterial activity of plasma using real 
saliva or artificial saliva with added factors from real saliva.
Our finding that post-plasma treatment incubation amplifies bactericidal effects suggests that similar, 
longer-term effects may also occur in vivo. Although plasma effects have been reported as short-lived in previous 
studies31, 32, we found CFU reductions for at least 30 min after plasma treatment. This result may indicate that 
long-life active species are produced by plasma treatment in artificial saliva or saline during the incubation time. 
Longer-lasting sterilization efficacy has also been observed in plasma-treated solutions33–35. Based on our results, 
it may be inferred that the bactericidal effect of the oral environment can last for a while after plasma treatment. 
Finally, microwave plasma may dually affect pathogenic bacteria and gingival tissues through bacterial inactiva-
tion and inflammatory response suppression (as evidenced by TNF-α release), while preserving gingival cell via-
bility. We observed that the same dose of microwave plasma that generated antibacterial activity also suppressed 
cytokine production in response to LPS stimulation. Furthermore, both effects occurred without adverse effects 
to gingival cell viability up to 24 h. These findings are noteworthy given that prior studies have demonstrated 
pro-apoptotic effects of plasma on mammalian cells36–38, and the findings support the notion that plasma therapy 
may be useful to control oral diseases complicated by bacterial infection.
The present results provide several clues regarding the mechanisms of action of microwave-pulsed NTAPP. 
Temperature and NO level did not appear to be the main factors responsible for the greater bactericidal effect 
of plasma in artificial saliva. According to our principal component analysis, treatment time, pH, and OH rad-
ical level affected bacterial viability in artificial saliva, but NO level was not correlated with bacterial viability 
(Supplementary Table S1). These findings indicate that additional factors, such as chemical alteration, may be 
responsible for the greater bacterial inactivation in artificial saliva.
Because several chemicals are present in artificial saliva, chemical alteration or generation of long-life species 
can be expected during interaction with plasma. Chemical analysis of artificial saliva treated with plasma should 
be performed in future studies. In this study, we found that removal of individual chemicals from the artificial 
saliva did not affect plasma-induced bacterial inactivation. Although removal of urea seemed to diminish the 
Figure 3. Scanning electron micrographs of S. aureus in artificial saliva after 5-min treatment with gas only 
(upper) or plasma (lower). Magnification, 50,000x.
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Figure 4. Changes in pH, OH radical level, and NO level in saline or artificial saliva after plasma treatment for 
1 min or 5 min. (a) pH of saline and artificial saliva after gas or plasma treatment. (b) OH radical level in saline 
and artificial saliva after gas or plasma treatment. (c) Levels of NO species in saline and artificial saliva after gas 
or plasma treatment. Levels of OH radical and NO are indicated by fluorescence intensity of terephthalic acid 
(TA) and 4-Amino-5-Methylamino-2′,7′-Difluorofluorescein combined with OH radical and NO, respectively. 
All values are means ± standard deviations of nine measurements. *P < 0.05.
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short-term bactericidal effects of plasma, the effect was trivial. Thus, synergistic chemical effects from interactions 
between plasma and multiple individual chemicals may play important roles in generating the bactericidal effect 
of plasma in artificial saliva. We did not identify any chemical composition changes in the artificial saliva that 
resulted from the plasma treatment, but we will explore this topic in our future investigation.
Based on our results, reactive species clearly play a crucial role in bacterial killing, although NO did not appear 
to contribute to bacterial inactivation in artificial saliva. NO may have benefitted HGFs viability and reduced 
inflammatory signaling, as it is known to do39, 40, especially in periodontitis41. Relatively greater OH radical levels 
in artificial saliva than in saline after plasma treatment may explain, in part, the enhanced bactericidal efficacy of 
plasma in artificial saliva.
Figure 5. Bacterial viability, as determined by CFU on a log scale after gas or plasma treatment for 1 min, 
3 min, or 5 min in saline and artificial saliva missing components. All values are means ± standard deviations of 
triplicate measurements.
Figure 6. Inactivation of bacteria after treatment with direct plasma or plasma-exposed solutions. All 
treatments were performed for 5 min. Bacterial inactivation was indicated by relative viability of plasma-treated 
bacteria compared to gas only-treated bacteria. Relative viability (%) = (CFU after plasma treatment/CFU after 
gas treatment) ×100. All values are means ± standard deviations of triplicate measurements.
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Lastly, greater bacterial inactivation with direct plasma exposure in artificial saliva (rather than in 
plasma-pretreated artificial saliva) indicates that chemical alteration itself cannot sufficiently explain the bacteri-
cidal efficacy of plasma in artificial saliva. Rather, the direct exposure of bacteria to plasma or plasma-generated gas 
throughout treatment may be important for bacterial killing. Although plasma-treated solutions can also inactivate 
bacteria34, 35, 42, direct contact between plasma and bacteria more rapidly sterilizes than does the indirect method43. 
This difference in efficacy may be related to reactive species with very short half-lives or free electron accumulation 
within plasma being crucial for bacterial inactivation. Further studies are needed to examine these possibilities.
Conclusion
In this study, microwave-pulsed NTAPP was used to control bacterial contamination in artificial saliva, 
and plasma effects on gingival tissue cells were identified. The results suggest that antibacterial activity of 
microwave-pulsed NTAPP can be enhanced in artificial saliva with inflammatory response suppression in 
Figure 7. (a) Viability of plasma-treated human gingival fibroblasts (HGFs); *P < 0.05. All measurements 
were performed nine times. (b) Viability of HGFs stimulated with a range of lipopolysaccharide (LPS) 
concentrations. All measurements were performed three times. (c) Viability and tumor necrosis factor alpha 
release by HGFs treated or not with plasma (1 min, 3 min, 5 min, and 10 min) after 1.0 µg/ml LPS stimulation; 
*P < 0.05 vs con(−) (no LPS or plasma). All measurements were repeated eight times.
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gingival cells. Although further investigations are required in vivo, our results suggest that microwave-pulsed 
NTAPP may be a useful alternative tool in clinical treatment of periodontal diseases because of its dual effects of 
bacterial inactivation and suppression of cellular inflammation.
Materials and Methods
Microwave-pulsed non-thermal atmospheric pressure plasma and sample treatment. 
Microwave-pulsed NTAPP was used in the study. The plasma impedance system consisted of a solid-state power 
oscillator, circulator, directional coupler, three-stub tuner, gas-flow meter, and plasma generator (Fig. 1a). A 
radio frequency signal generator (Agilent, Santa Clara, CA, USA) was connected to the resonators using an HY 
3005D-3 DC power supply (Mastech Power Supply, CA, USA), which used a frequency of 930 MHz and a power 
of 40 W. Ar was used as the feeding gas, with a degree of plasma ionization of 1013/cm3 and electron temperature 
of 1.2 eV44.
Because extended plasma discharge produces heat, we determined optimal treatment conditions for antibac-
terial and cellular activities without thermal effect. The distance between the end of the plasma plume or gas flow 
and upper surface of the solution containing bacteria or cells was set at 10 mm (Fig. 1c). Feeding gas, frequency, 
and power were maintained as described above. Samples treated with Ar gas only were used as controls. Ions and 
radicals generated by plasma were characterized using an optical emission spectroscope comprised of a collima-
tor lens, optical fiber-core (diameter, 600 µm), and spectrometer.
Antibacterial activity test. Two to three S. aureus colonies were suspended in 1.8 ml Luria-Bertani (LB) 
liquid and then 10 µl of this suspension was inoculated into 15 ml of new LB liquid. After incubation at 37 °C for 
16 h with shaking at 140 rpm, bacteria were washed with saline (0.85% NaCl solution) once and re-suspended in 
new saline. Then, the bacterial suspension was diluted to reach a 1.0 absorbance at 600 nm wavelength with 106 
bacterial cells per ml. The diluted bacterial suspension was divided into two conical tubes (20 ml per tube) and 
centrifuged at 3134 × g for 5 min. After discarding the liquid, the bacterial pellet was re-suspended in 20 ml of 
saline or artificial saliva. The artificial saliva was prepared following the Fusayama-Meyer method45. The chem-
ical composition of the artificial saliva is shown in Table 1. Supplementary Table S2 illustrates the composition 
of artificial saliva solutions after omission of individual chemicals. Aliquots of 1 ml of bacterial suspension (106 
cells) in saline or artificial saliva were placed on Petri dishes and exposed to plasma or Ar gas (control) for 1 min, 
3 min, 5 min, or 7 min. After plasma or Ar gas exposure, the bacterial suspension was transferred to microtubes 
and incubated at room temperature for 0 min or 30 min. Next, the bacterial suspensions were serially diluted and 
100 µl of the diluted suspension was spread onto LB agar plates. Plates were incubated at 37 °C overnight; CFU 
were counted the next day. All experiments were conducted three times. The same procedure was applied to bac-
teria treated with plasma in artificial saliva that had individual chemicals omitted.
Scanning electron microscopy. Bacterial cell morphology after plasma treatment was determined using 
a field-emission scanning electron microscope (JEOL 7100F, Tokyo, Japan). Bacterial cells in artificial saliva were 
treated with plasma or Ar gas (control) for 5 min, as described previously. Next, bacterial cells were washed with 
saline three times and then processed further for scanning electron microscopy (SEM) analysis, following previ-
ously described procedures46. Platinum-coated samples were used for SEM at 5 kV and 50,000× magnification.
Temperature, pH, and reactive species analyses. Solution pH and temperature were measured with 
a portable pH meter (Oakton Instruments, Vernon Hills, Il, USA) and an infrared thermometer (Mini Infrared 
Thermometer Model SK-8700, SATO Keiyoki Co., Ltd, Tokyo, Japan) immediately following exposure to plasma 
for 1 min or 5 min. Untreated distilled water was used as a reference control. We also assessed ROS and reactive 
nitrogen species in plasma-treated solutions by measuring OH and NO levels, respectively. Terephthalic acid 
(TA, Sigma Aldrich, Winooski, VT, USA) was dissolved in saline or artificial saliva (20 mM concentration) and 
then the solutions were exposed to plasma or Ar gas (control) for 1 min or 5 min. Fluorescence emission level 
by hydroxy-TA was measured at 310ex/425em nm with a multi-detection microplate reader (BioTek, Winooski, 
VT, USA). To detect NO, 4-Amino-5-Methylamino-2′,7′-Difluorofluorescein (DAF-FM, Life Technologies, 
Carlsbad, CA, USA) was used. After treatment with plasma or Ar gas, DAF-FM was added immediately to the 
solutions to achieve a final concentration of 1 µM. Lastly, fluorescence was monitored at 495ex/515em nm using a 
multi-detection microplate reader.
Cellular response analysis. HGFs (CRL-2014, ATCC, Manassas, VA, USA) were obtained between pas-
sages three and seven for treatment with gas only or plasma, using the same conditions used in the antibacterial 





CaCl2 · 2H2O 5.4
NaH2PO4 · 2H2O 5.0
Na2S · 9H2O 0.021
Urea 16.5
Table 1. Components of saline and artificial saliva.
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activity experiment. Cell suspensions of 1 ml (1 × 104 cells) were placed in each well of a 24-well plate and 
then treated with plasma for 1 min, 3 min, or 5 min. After treatment, HGFs viability was determined using the 
EZ-CyTox WST assay (Daeillab, Seoul, Korea) following the manufacturer’s instructions.
The influence of plasma treatment on inflammatory cytokine secretion was determined by examining TNF-α 
release from cells. HGFs (1 × 104 cells) treated with or without plasma were stimulated with LPS (Sigma-Aldrich, 
St. Louis, MO, USA) to induce inflammation. Based on the results, 1.0 µg/ml of LPS concentration was cho-
sen to induce inflammation. WST assays were performed to determine cell viability after 24 h. Untreated cells 
[con (−)] and LPS-treated cells without plasma [LPS only] were used as controls. The experimental groups 
included untreated normal cells designated as con (−), LPS-stimulated cells, and plasma-treated, LPS-stimulated 
cells. TNF-α concentrations in culture supernatants were measured by enzyme-linked immunosorbent assay 
(BioVision, Inc., Milpitas, CA, USA).
Statistical analysis. Quantitative data are reported as means ± standard deviations. Because the sample 
number in each group was small (3 to 9), the Mann-Whitney U test was used to compare groups47. Statistical 
significance was determined by a P value less than 0.05.
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